Chiasma's Debt Round

Chiasma raised a round of funding on November 23, 2009.

Chiasma (NASDAQ: CHMA) is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases by developing and commercializing oral medications that were previously available …

Articles about Chiasma's Debt Round: